Stephen Yu
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Cancer Genomics and Diagnostics
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Oncology 3
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- John A. Provet (1 shared paper)Ryan D. Morin (3 shared papers)Marco A. Marra (1 shared paper)Nathalie A. Johnson (2 shared papers)Daniel Fornika (1 shared paper)David R. Kroeger (1 shared paper)Joseph M. Connors (1 shared paper)Zusheng Zong (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Blood (2 papers)Molecular Cancer Therapeutics (1 paper)Hematological Oncology (1 paper)The Journal of Urology (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Stephen Yu
11 papers receiving 510 citations
Peers
Comparison fields: 5 of 32
- Pathology and Forensic Medicine 288
- Cancer Research 55
- Oncology 84
- Genetics 15
- Immunology 32
Countries citing papers authored by Stephen Yu
This map shows the geographic impact of Stephen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Yu more than expected).
Fields of papers citing papers by Stephen Yu
This network shows the impact of papers produced by Stephen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Yu. The network helps show where Stephen Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 191 | |
| 2 | 2016 | 125 | |
| 3 | 2020 | 91 | |
| 4 | 2020 | 52 | |
| 5 | 2015 | 23 | |
| 6 | 2017 | 21 | |
| 7 | 1992 | 11 | |
| 8 | 2019 | 2 | |
| 9 | 2020 | 2 | |
| 10 | 2022 | 2 | |
| 11 | 2025 | 1 |
About Stephen Yu
Stephen Yu is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Urology and Cancer Research, having authored 11 papers that have together received 521 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Antifungal resistance and susceptibility (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Cancer Genomics and Diagnostics (1 paper), Urinary Bladder and Prostate Research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (288 citations), Cancer Research (55 citations), Oncology (84 citations), Genetics (15 citations) and Immunology (32 citations). Stephen Yu has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include John A. Provet, Ryan D. Morin, Marco A. Marra, Nathalie A. Johnson, Daniel Fornika, David R. Kroeger, Joseph M. Connors, Zusheng Zong, Steven Peter Treon and Mark Basik. Their work appears in journals such as Clinical Cancer Research, Blood, Molecular Cancer Therapeutics, Hematological Oncology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.